Barr Pharma (BRL) Higher On Reports Teva (TEVA) Could Buy The Company
More News related to BRL
- Barr Will Host An Earnings Conference Call on November 6, 2008 to Discuss the Results for the Third Quarter of Calendar 2008
- Ready and Willing, but Unable? Survey Reveals Boomers Desire Sex, But Face Physical Challenges
- Barr Pharmaceuticals (BRL) Receives FDA Approval for Generic Razadyne
- Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules
- Teva (TEVA) and Barr (BRL) Receive FTC Second Request Regarding Pending Acqusition
More News related to TEVA
- Teva Neuroscience Launches Spanish Parkinson's Disease Patient and Caregiver Web Site
- Unusual 11 Mid-Day Movers 9/26: IDEV, VSE, OSK, AEHR Higher; WM, NCC, SDA, WB Lower
- Indevus (IDEV) Announces Agreement With Teva (TEVA) to Develop Pagoclone for the Treatment of Stuttering
- Needham & Co Initiates Coverage on Drugs - Generic
- Stanford Starts Teva Pharmaceuticals (TEVA) at Buy
More News related to Mergers and Acquisitions
- Banco Santander, S.A. (STD) to Acquire Sovereign Bancorp (SOV)
- QCR Holdings (QCRH) to Sell First Wisconsin Bank & Trust for $13.5M
- Diebold (DBD) Comments on Withdrawal of Bid From United Technologies (UTX); Increases FY08 EPS Guidance
- Telefonica S.A. (TEF) Increases Offer to Acquire Compania de Telecomunicaciones de Chile
- Wells Fargo (WFC) Insurance Services Acquires EMAR Group
Barr Pharmaceuticals Inc. (NYSE: BRL) is over 10% higher in after-hours action on reports from Globes Online that Teva Pharmaceutical (Nasdaq: TEVA) is in talks to buy the company for over $5 bilion.
Related Categories
Hot ListMergers and Acquisitions
Rumors
Stocks Mentioned
+5.86Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
